We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
- Authors
Jabbour, Elias; Sasaki, Koji; Haddad, Fadi G.; Issa, Ghayas C.; Skinner, Jeffrey; Dellasala, Sara; Yilmaz, Musa; Ferrajoli, Alessandra; Bose, Prithviraj; Thompson, Philip; Alvarado, Yesid; Jain, Nitin; Garcia‐Manero, Guillermo; Takahashi, Koichi; Borthakur, Gautam; Pemmaraju, Naveen; Pierce, Sherry; Kantarjian, Hagop
- Publication
American Journal of Hematology, 2022, Vol 97, Issue 11, p1413
- ISSN
0361-8609
- Publication type
Article
- DOI
10.1002/ajh.26689